Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 7Recruiting 4Unknown 2Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 19Ovarian Neoplasms 9Uterine Cervical Dysplasia 6Breast Neoplasms 4Neoplasms 3Uterine Neoplasms 2Triple Negative Breast Neoplasms 2Prostatic Neoplasms 2Endometrial Neoplasms 2Depression 2Colorectal Neoplasms, Hereditary Nonpolyposis 2Colorectal Neoplasms 2Cervical Cancer Screening 2Carcinoma, Non-Small-Cell Lung 2Anxiety Disorders 2Vulvar Neoplasms 1Vaginal Neoplasms 1Urinary Bladder Neoplasms 1Treatment Adherence and Compliance 1Tinnitus 1Thyroid Neoplasms 1Tension-Type Headache 1Stroke 1Stress Disorders, Post-Traumatic 1Stomach Neoplasms 1Squamous Intraepithelial Lesions of the Cervix 1Squamous Intraepithelial Lesions 1Squamous Cell Carcinoma of Head and Neck 1Spinal Stenosis 1Spinal Cord Injuries 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Carcinoma in Situ × Gynecologic × Clear all
NCT04755517 2025-01-13

HPV400

Tampere University Hospital

Phase NA Enrolling by invitation
14,000 enrolled
Gynecologic

Carcinoma, Carcinoma in Situ, Uterine Cervical Dysplasia, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Glandular and Epithelial, Adenocarcinoma in Situ

Data powered by HemOnc (CC BY 4.0) Colophon âš¡